Stomach acid is often treated with medications such as Pepcid, but that could put long-term care residents or hospitalized patients at risk for Clostridium difficile, according to a new analysis.
Limiting use of common antihistamines could reduce C. diff in facilities, researchers say
By
McKnight's Staff
Mar 29, 2013
Taking antihistamines such as Tagamet, Pepcid and Zantac increases the risk that people in healthcare settings will be infected with Clostridium difficile, according to a recently published study.